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Depression and stress: is there an endophenotype?
Depressão e estresse: existe um endofenótipo?
Abst rac t
Objective: To review the new findings about stress, hypothalamic-pituitary-adrenal axis and depression trying to explain a
possible endophenotype prone to depression. Method: Nonsystematic review of the literature based on the endophenotype
hypothesis. Results: Depression is linked to hypercortisolemia in many patients, but not all patients present these hypothalamic-
pituitary-adrenal axis dysfunction. The dexamethasone suppression test is not the most accurate test to measure the hypothalamic-
pituitary-adrenal axis function, and its use in the first studies published probably jeopardized the results. Hypercortisolemia
frequently occurs in patients with severe depression, melancholic, either psychotic or nonpsychotic type; it is linked to the
presence of a polymorphism in the promoter of the serotonin transporter gene, with a history of childhood abuse or neglect, or
other significant stressful experiences like the loss of a parent during childhood and temperament leading to alterations in the
response to stress. Conclusions: The alterations of the hypothalamic-pituitary-adrenal axis depend on many factors like severity
and type of depression, genotype, history of exposure to stress, temperament, and probably resilience. All these factors together
result in an endophenotype thought to be prone to depression.
Descriptors: Depression; Corticotropin releasing hormone; Hypothalamus-hypophyseal system; Pituitary-adrenal system; Stress
Resumo
Objetivo: Revisar os achados recentes sobre a relação entre estresse, eixo hipotálamo-pituitária-adrenal e depressão, na tenta-
tiva de explicar um endofenótipo de vulnerabilidade para o desenvolvimento da depressão. Método: Revisão não sistemática da
literatura baseada na hipótese de endofenótipo. Resultados: A depressão está relacionada à hipercortisolemia em muitos
pacientes; porém, nem todos os deprimidos apresentam esta alteração na função hipotálamo-pituitária-adrenal. Os primeiros
estudos publicados observaram esta hiperativação do eixo hipotálamo-pituitária-adrenal por meio do teste de supressão da
dexametasona. Estes resultados não foram largamente replicados em grande parte devido à falta de acurária desse teste. A
hipercortisolemia ocorre freqüentemente em pacientes com depressão grave, do tipo melancólico, psicóticos ou não. Está relacionada
a um polimorfismo específico do gene do transportador da serotonina; a história de abuso ou negligência durante a infância ou
perda parental precoce; e ao temperamento que resulta em alterações na resposta ao estresse. Conclusões: As alterações do
eixo hipotálamo-pituitária-adrenal dependem de diversos fatores, como gravidade e tipo de depressão, genótipo, história de
trauma na infância, temperamento e, provavelmente, resiliência. Todas essas variáveis se relacionam a um endofenótipo vulnerá-
vel ao desenvolvimento de depressão.
Descritores: Depressão; Fator de liberação de corticotrofina; Sistema hipotálamo hipofisário; Sistema hipófise supra-renal; Estresse
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Int roduct ion
Hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis
in major depression is one of the most consistent findings in
psychiatry. A significant percentage of patients with major
depression have been shown to exhibit increased concentrations
of cortisol (the endogenous glucocorticoid in humans) in the
plasma, urine and cerebrospinal fluid (CSF); an exaggerated
cortisol response to adrenocorticotropic hormone (ACTH); and
an enlargement of both the pituitary and adrenal glands.1 In
the last several years, many studies about the HPA axis in
depressed patients have been published, and it seems that there
is a new perspective for these old finding of hypercortisolemia.
The knowledge about it is converging to some directions,
hypercortisolemia is apparently linked to some specific cases of
depression and it depends on the type and severity of the illness,
genotype, history of stress during childhood, and probably
resilience, leading us to believe that there is an endophenotype
prone to depression. We intend to summarize in this article
some of the findings that support this hypothesis.
Background
The first studies about hypercortisolemia in depressed patients
were published in the seventies, back then Carroll et al. have
found that severely depressed patients had non suppression in
the dexamethasone suppression test (DST).2 The DST showed
that a high proportion of patients with various affective disorders
had elevated cortisol levels, thus escaping the suppressive effect
of dexamethasone. Unfor tunately, dexamethasone has
pharmacodynamic and pharmacokinetic features that are very
distinct from those of the human endogenous glucocorticoid,
cortisol. These features, together with the low (40-50%)
sensitivity of the DST in detecting patients with major
depression, have strongly limited the use of this test in routine
clinical and research practice.3 The use of the DST resulted
in conflicting findings that were not widely replicated and the
studies about the HPA axis function in depression were left
apart for some time.
Besides the limitation of the DST, many factors work as
confounders biasing the results of stress tests able to measure
the HPA axis function. Most of the studies have included mixed
populations with diagnosis of both posttraumatic stress disorder
(PTSD) and depression with patients with different severity
degrees of illness and with and without a history of early life
stress that made the results nonreplicable.
Nearly ten years after the development of the DST, Holsboer
et al. have developed a more sensitive neuroendocrine function
test to detect HPA axis dysregulation. It combines the DST and
the corticotrophin releasing hormone (CRH) stimulation test
and its called the DEX/CRH challenge test.4-5 The test involves
oral administration of a single dose of dexamethasone (DEX)
1.5 mg at 11 pm, followed the next day at 3 pm by an
intravenous bolus of CRH 100 μg. Since then, Holsboer et al.
have been publ ishing interest ing resul ts about
hypercortisolemia and depression.
Recently, Watson et al. have examined if the DEX/CRH test
unveils subtle HPA axis disturbance not detected by the DST
in patients with mood disorders and controls.6 They have found
a close correlation between the cortisol responses on the two
tests. The sensitivity of DEX/CRH was 61.9%, and the
specificity was 71.4%. The sensitivity of DST was 66.6%,
and the specificity was 47.6%. This suggests that the two
tests measure common pathology, but that the DEX/CRH test
has better diagnostic utility.
Zobel et al. have described a cohort of patients receiving
the DEX/CRH test on two different moments: after starting the
first antidepressant treatment; secondly, a few days before the
discharge.7 The authors have found that those patients who
had an increase in cortisol levels after the DEX/CRH test
between admission and discharge tended to relapse during
the follow-up period, whilst those who showed a decrease in
the post DEX/CRH cortisol levels tended to remain clinically
stable in the follow-up period. In general, HPA axis changes
appear to be state dependent, tending to improve upon
resolution of the depressive syndrome.8
Recently, a suppressive test using another synthetic
glucocorticoid, prednisolone has been developed by Pariante
et al., such test has a higher affinity for the mineralocorticoid
receptor (MR) and, therefore, should probe both receptors.9
Glucocorticoids mediate their actions, including feedback
regulation of the HPA axis, through two distinct intracellular
corticosteroid receptor subtypes referred to as the type I or
mineralocorticoid receptor, and the type II or glucocorticoid
receptor (GR), see Figure 1. In contrast to the MR, the GR
has a high affinity for dexamethasone and a lower affinity for
endogenous corticosteroids. However, most of the literature
in this field has examined the GR. The first results with the
prednisolone test in depressed patients seem to confirm the
notion that MR-mediated negative feedback in depression is
intact in depressed patients.10
Although different tests have been used and conflicting results
have been published, there are some converging results in
the specific case of depression. Hypercortisolemia frequently
occurs in patients with severe depression, melancholic, either
psychotic or nonpsychotic type, it is linked to the presence of
a polymorphism in the promoter of the serotonin transporter
gene, with a history of childhood abuse or neglect, or other
significant stressful experiences like the loss of a parent during
childhood and temperament leading to alterations in the
response to stress.12 All these factors together result in an
endophenotype thought to be prone to depression.
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Another group of states is characterized by hypoactivation
of the stress system, rather than sustained activation, in which
ch ron i ca l l y  r educed  sec re t i on  o f  CRH may  r esu l t  i n
pathological hypoarousal and an enhanced HPA negative
feedback. Patients with atypical and seasonal depression fall
in  th i s  ca tegory 13 a l though in  th is  a r t i c le  we wi l l  no t
emphasize this last group of patients.
Severity and type of depression
A hyperfunction of the HPA axis, characterized by a CRH
hyperdrive, reduced negative feedback and hypercortisolism, has
been a consistent research f inding in major depression.
Classically, the abnormalities have been observed in patients with
unipolar disorder (one or recurrent major depressions), but they
can also be present in the depressive phase, the manic phase
and the remission phase of patients with bipolar affective disorder
(recurrent episodes of both major depression and mania or
hypomania).14-15 In one study, Young et al. have found that anxiety
disorders occur in approximately 30% of patients with major
depressive disorder and have concluded that depressed patients
with comorbid anxiety disorders show even greater impairment
of the negative feedback on the HPA axis than that observed in
depressive patients without comorbid anxiety disorders.16
In the last decades, several studies have reported that psychotic
major depression (PMD) has unique characteristics including
neuroendocrine differences from nonpsychotic major depression. Many
studies found hyperactivity of the HPA axis in PMD patients.17-19
More recently, Gomez et al. have examined 29 patients with
PMD, 24 nonpsychotic major depressive patient (NPMD) and
26 healthy control subjects who were recruited at Stanford
University Medical Center.20 Psychiatric ratings, cortisol levels
from 6 pm-9 am, and neuropsychological test data were obtained.
The results showed that PMDs had elevated mean cortisol levels
from 6 pm to 1 am.
Contreras et al. have also studied 40 inpatients meeting DSM-
III-R criteria for major depressive episode with melancholia
(21 nonpsychotic and 19 psychotic). DST, TSH-TRF and GH-GRF
tests were undertaken by all patients. The results for disturbances
of the HPA axis showed up to 80% alterations in melancholic
depressive patients (whether psychotic or nonpsychotic), and that
these disturbances may relate more to the presence of psychotic
symptoms. The importance of HPA axis dysfunction in melancholia
is clearly suggested. Only 20% of the whole sample (23.9% in
nonpsychotic and 15.8% in psychotic depression) had no
disturbance in any hormonal axis.21
Keller et al. have studied patients with depression with psychotic
symptoms (PMD) and without (NPMD) and healthy control subjects
using rating scales of depression and psychosis and measures of
HPA activity, including overnight cortisol and adrenocorticotropin
levels.22 Thirty-seven PMD and 32 NPMD participated in the study.
The results showed that PMDs had higher cortisol during the
evening hours than did NPMDs or control subjects, who did not
differ from one another. Regression analyses suggest that
depression and the combination of depressive and psychotic
symptoms were important contributors to the variance in evening
cortisol levels. PMD is associated with increased cortisol levels
during the quiescent hours. Enhanced cortisol activity, particularly
a higher nadir, was related to depression severity and the
interaction of depressive and psychotic symptoms. This increase
suggests a defect in the action of the circadian timing system
and HPA axis, creating a hormonal milieu similarly to that seen
in early Cushing’s syndrome and potentially an (im)balance of
mineralocorticoid and glucocorticoid receptor activity.
Genet i cs
There are conflicting evidence concerning the relationship
between a polymorphism in the promoter of the serotonin
transporter gene (SLC6A4) and risk for depression.23 After
the publication of the study by Caspi et al. in 2003,24 many
studies replicated the results found and some did not. Caspi’s
research team found that childhood maltreatment predicted
adult diagnosed depression among individuals carrying at
least one copy of the short allele. This polymorphism of the
serotonin transporter gene (5-HTTLPR) consists of a 20-23
base pair sequence that is repeated either 14 (short) or 16
(long) times, with the presence of the short(s) allele putatively
conferring greater risk for depression, particularly for people
who have experienced stress recently or early in life. They
also found that people with one or more s alleles who were
exposed to adult stressful life events were more likely to develop
depression than those homozygous for the long (l) allele.
Many studies have replicated these data.25-28
Wilhelm et al. have examined 127 subjects, associations
were investigated between the 5-HTTLPR genotype, positive
and adverse life events and the gene X environment interaction.29
The results showed that adverse life events had a significantly
greater impact on the onset of depression for individuals with
the s/s genotype than for the s/l or l/l, concluding that the 5-
HTTLPR genotype is a significant predictor of onset of major
depression following multiple adverse events.
Zalsman et al. have examined the  relationship of a
triallelic 5-HTTLPR polymorphism to stressful life events,
severity of major depression, and suicidality.30 One hundred
and ninety-one (191) mood disorders subjects were
compared to 125 healthy volunteers; all subjects were
genotyped for the triallelic 5-HTTLPR polymorphism and
underwent structured clinical interviews to determine DSM-
IV diagnosis, ratings of psychopathology, stressful life events,
developmental history, and suicidal behavior. The results
showed that lower expressing alleles (L
G
, S) independently
predicted greater depression severity and predicted greater
severity of major depression with moderate to severe life
events compared with the higher expressing L
A
 allele. The
research group concluded that lower expressing transporter
alleles, directly and by increasing the impact of stressful
life events on severity, explain 31% of the variance in ma-
jor depression severity
However, Surtees et al. have reported that adversity in
childhood and adulthood was associated with major
depressive disorder, defined by DSM-IV diagnostic criteria,
but these relations did not interact with the 5-HTTLPR
genotype.31 Gillespie et al. have also reported no replication
of the pattern identified by Caspi.32
Stress during childhood
An extensive literature, dating back to the work of Freud,
describes observations and theories regarding the importance
of early maternal attachment in, and the impact of maternal
deprivation on, the development of adult psychological health.
Much descriptive work has been published on the relationship
between adult psychopathology and early adversities such
as parental loss in childhood, inadequate parental care,
divorce, ‘affectionless’ or dysfunctional parenting, childhood
physical and sexual abuse, and other childhood traumas.
These studies have consistently found early life stressors to
be associated with increased risk for mood and anxiety
disorders and personality pathology in adulthood.33
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Increasing evidence indicates that childhood neglect and
abuse are risk factors for both adolescent- and adult- onset
depression.34-36 Since the HPA axis is activated in response
to stressors, early life stressful events may also have an
etiologically significant role in the HPA axis abnormalities
found in depression.37
Cortisol dysregulation and deficient glucocorticoid feedback
regulation have been repeatedly identified as biological
correlates of adult depression and anxiety disorders38-39  and
early life adversity is consistently associated with these
disorders in epidemiological studies.40 A large body of clinical
literature has characterized major depressive disorder (MDD)
as a condition associated with excessive basal cortisol
secretion and inadequate inhibitory feedback regulation of
the HPA axis constituents.41 Childhood maltreatment is
another example of a risk factor for depression that has
been examined in nonclinical samples. In a study by Heim
et al., women with a history of sexual or physical abuse
demonstrated increased ACTH but normal cortisol responses
to the TSST when compared with female control subjects
without abuse histories.42
Moskvina et al. have studied the relationship of childhood
trauma (CT) to age of onset (AO) of depression, personality
traits, and expression of symptom dimensions in 324 adults
with recurrent unipolar depression.43 Subjects received
structured psychiatric interviews and completed CT, depressive
symptom, and personality rating questionnaires. Experience
of at least one type of trauma was reported by 79.9% of
subjects, and the most common forms of trauma were physical
neglect, emotional abuse, and emotional neglect. There was
an earlier AO of depression in the groups that reported CT
compared to those that reported none, with earliest AO
occurring in those who had experienced the highest levels of
CT. The effect of CT on individuals with an underlying genetic
vulnerability to depression may result in differences in
depressive phenotype characterized by earlier AO of depression
and the expression of specific depressive symptom dimensions.
Recent studies have shown that depressed patients with a
history of childhood trauma and chronic forms of major
depression are more likely to show hyperactivity of the HPA
axis and to present symptoms that are resistant to standard
antidepressants, but instead benefit from adjuvant treatment
with psychotherapy.44 It has been concluded from these studies
that child maltreatment may lead to disruptions in HPA axis
functioning, and that factors such as age of maltreatment,
parental responsiveness, subsequent exposure to stressors, type
of maltreatment, and type of psychopathology or behavioral
disturbance displayed may influence the degree and pattern
of HPA disturbance. However, results from studies examining
the relationship between child maltreatment, psychopathology
and the HPA axis do vary. While most studies report HPA axis
dysregulation, inconsistencies have been noted. Furthermore,
results should be analyzed by gender and by type of stressor
for maximum consistency, as the effects on the HPA axis may
vary due to these factors.
Temperament
Temperament and personality characteristics such as
behavioral inhibition and neuroticism have been linked to
mood and anxiety disorders. For example, prospective studies
of nondepressed individuals have shown that neuroticism,
which can be characterized by the tendency to experience
negative affect, is a risk factor for the subsequent development
of depression.40,45-46 Moreover, findings from behavioral and
molecular genetics studies indicate that neuroticism and ma-
jor depression share common genetic risk factors.47-48
Behavioral inhibition is another temperament factor that has
been found predictive of anxiety disorders and depression.49
This trait, defined as the tendency to withdraw and avoid novel
situations, demonstrates stability over time in both non-human
primates50 and children. Behavioral inhibition has been linked
to anxiety disorders in family studies and in prospective longi-
tudinal studies of young children who have been followed
through childhood and into adolescence.51-53
Stressful life experiences also play a prominent role in the
development of major depression,54-55 several lines of research
suggest the possibility that personality or temperament may
account for  some of  the associat ion between st ress,
depression, and HPA axis hyperactivity. There is evidence
that personality can influence the likelihood of exposure to
stressors. In addition to altering exposure, personality or
temperament may confer sensitivity to stressors and conversely,
a temperament-based tendency to experience negative affect
or to be socially inhibited may in part result from psychological
or physiological sensitivity to stressors.40,56-57
Our research group reported lower levels of Novelty Seeking
predicting higher cortisol concentrations in response to the
DEX/CRH test in healthy adults. The findings of this study
support the hypothesis that personality factors, which may
reflect increased sensitivity to stimuli, are predictive of
enhanced activation of the HPA axis. Low levels of Novelty
Seeking, which reflect an introverted, rigid temperament, were
predictive of greater cortisol responses to the DEX/CRH test.58
Discuss ion
Could the HPA axis dysfunction be seen as the primary
biological cause of major depression, or is it a secondary
phenomenon? There are several indications in our data and
in the literature that the HPA axis has a primary role in the
predisposition and the onset of major depression. The HPA
axis is a major element of the stress system and both acute
and chronic stress can elicit major depression.59 Interestingly,
early-life stress leads to persistent neurobiological adaptations
that resemble the findings in depression. There is a correlation
between stress, HPA axis (responsible for the stress response)
and the development of depression that is becoming clearer.
Holsboer et al. have found that the HPA feedback impairment
observed among patients with depression was also present
in otherwise healthy individuals who are at risk because they
have a first-degree relative with an affective i l lness.60
Moreover, this disturbance was shown to be stable over a
four-year period.61 These data suggest that some individuals
have a genetically determined vulnerability to develop a
chronic HPA axis hyperdrive and possibly major depression.
There is also a link between genetics, the HPA axis function
and vulnerability to depression.
To better understand the development of depression we
can make a correlation between many factors, starting from
genotype that includes heritability, childhood environment
that includes possible traumas, temperament that gives to
the individual the capacity to deal with the environment,
and the resilience of some subjects that can explain different
types of response to the same stressful events. The HPA axis
is one of the most important systems to be studied to elucidate
the etiology of depression, but many other factors also need
to receive attention.
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The knowledge in this area of interest is becoming more
consistent, we know more about the limitations of the stress
tests and about confounding factors in this research field.
The endophenotype hypothesis linking many findings about
gene versus environment is not only being studied in the
case of depression, but in many others illnesses; it is the
tendency for the present.
Conclus ions
The above observations are suggestive of an etiological role
of the HPA axis in major depression; however, it is important
to keep in mind that major depression is a complex and
heterogeneous disorder. Whereas some subtypes of major
depression, such as psychotic major depression, are associated
with high rates of HPA axis hyperactivity, some depressed
patients do not exhibit any disturbance of HPA axis at all.  For
a better understanding the complex interplay between nature
and nurture in the development of depression in adults, future
studies should ideally consider as many factors as possible
trying to create a complete Environment versus Gene
interact ion. Such kind of research ideal ly connects
psychosocial and genetics, psychological and biological
approaches for better understanding mental illnesses.
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